A NEW treatment for locally
advanced basal cell carcinoma
(laBCC) called Odomzo (sonidegib)
from Novartis has been approved
by the US Food and Drug
Administration.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
THE Pharmaceutical Society of Australia has paid tribute to Emeritus Professor Lloyd Sansom AO for his longstanding contribution to the Australian Pharmaceutical Formulary and Handbook, with the 24th edition (APF24) released yesterday.
SOUTH Australian coroner Mark Johns has recommended that laxative medications be removed from pharmacy front of shop and only made available with pharmacist advice, after an inquest into the death of an anorexic woman who was reportedly taking up to 800 tablets each day.